Loss of Function
Sjögren’s Disease
Genotype
SIL1 KO
Mechanism
Loss of Function
Phenotype
Reduced locomotor activity, Fatigue, Exploratory behavior, Anxiety, Social isolation, Sensory impairment
Biomarker
Aquaporin-5, Caspase-3, Anti-nuclear antibodies
Gene Expression Markers
HSPA5, DDIT3, ATF4, XBP1 , IL6, TNF,IFNG, CXCL13 ,BAX, CASP3, BCL2
Physiology Changes
Lethargy, ROS production
Histology Grading Endpoint
Dense periductal and perivascular lymphocytic aggregates, Progressive destruction of secretory acinar cells, Ductal epithelial hyperplasia



